
|Articles|August 1, 2017
Interpreting PSA levels in metastatic prostate cancer
In this Urology Times educational supplement, we review the changing relevance of PSA as prostate cancer advances through various stages.
Advertisement
Newsletter
Stay current with the latest urology news and practice-changing insights — sign up now for the essential updates every urologist needs.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Urology Times
1
Kristen Scarpato, MD, on combination strategies in BCG-naïve NMIBC
2
Trial to compare 225Ac-PSMA-617 vs 177Lu-PSMA-617 for oligorecurrent prostate cancer
3
Amanda North, MD, recaps SWIU 2026 session on imposter syndrome
4
Farah Rahman, MD, on monitoring resident wellness using biofeedback
5






